Bharath Sreekumar, a third-year Translational Biology, Medicine, and Health graduate student in the Oestreich laboratory received an Outstanding Abstract award at the 2018 annual Southeastern Immunology Symposium, hosted June 16-17th by the University of Alabama at Birmingham.

An article by VTCRI’s Ashley WennersHerron about our recent publication in The Journal of Immunology. “Scientists identify potential key to therapeutic treatments for autoimmune diseases”

For the full text of our recent Journal of Immunology article, click here:
http://www.jimmunol.org/content/early/2017/08/26/jimmunol.1700106

Ms. Kaitlin Read and Mr. Michael Powell are co-first authors for the Oestreich lab’s recent publication in The Journal of Immunology. For the full text of this article, please go to:
http://www.jimmunol.org/content/early/2017/08/26/jimmunol.1700106

Mr. Michael Powell, a 3rd-year graduate student in the Oestreich Laboratory, presented his work in poster format, entitled “Cooperative Activities between STAT3 and Ikaros Zinc Finger Transcription Factors Regulate Bcl-6 Expression in CD4+ T Helper Cells” at the American Association of Immunologists (AAI) annual meeting held in Washington DC.

Dr. Kenneth Oestreich and Ms. Kaitlin Read hosted a session for “VTC Camp”, run by the Science Museum of Western Virginia and hosted at VTCRI. The session included a brief lesson on our work, as well as the playing of an immunology trading card-based game designed and created by Dr. Oestreich and Ms. Read.

Ms. Kaitlin Read and Mr. Michael Powell are co-first authors for the Oestreich lab’s recent publication in Immunology. For the full text of this article, please go to:
http://onlinelibrary.wiley.com/doi/10.1111/imm.12648/full

Dr. Oestreich and third-year TBMH Graduate Student Michael Powell received a 2016 Careers in Immunology Fellowship through the American Association of Immunologists (AAI). This award will provide salary support for Mr. Powell for his project, “Identification of Novel Transcription Factors That Regulate the Expression of Bcl-6 and the TFH and TCM Gene Programs”, which seeks to provide molecular building blocks to inform the development of novel immunotherapeutics.